Effect of leech therapy in increased d-dimer laboratory values.
- Conditions
- Health Condition 1: D689- Coagulation defect, unspecifiedHealth Condition 2: D65- Disseminated intravascular coagulation [defibrination syndrome]Health Condition 3: I829- Embolism and thrombosis of unspecified veinHealth Condition 4: I998- Other disorder of circulatory systemHealth Condition 5: D686- Other thrombophiliaHealth Condition 6: I838- Varicose veins of lower extremities with other complications
- Registration Number
- CTRI/2022/12/048609
- Lead Sponsor
- Dr Nikita Saxena
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients those have increased D-dimer values in Deep vein thrombosis (DVT), Disseminated intravascular coagulation, Hepatomegaly and Post convalescence SARS Covid-19 patients(after 3 months)will be selected for study.
2.Participants of any gender in between 16 to 70 ages.
3.Participants who are willing for the study.
1.Absolute Hemophiliac and other bleeding disorders.
2.Anticoagulant medicines like Warfarin, Heparin, etc.
3.Severe Anemia.
4.Erosive Gastritis and potential gastrointestinal bleeding.
5.During Chemotherapy.
6.Individuals with HIV infection.
7.Severe Allergic Diathesis (allergy foreign proteins).
8.Hypotension
9.Active Tuberculosis.
10.Pregnancy
11.Mental disorders during acute episodes.
12.Severe ill and bed patient.
13.Acute DVT
14.Pulmonary Embolism
15.Malignancy
16.Participants who are known cases of renal failure, neurological, Diagnosed with CA, and also with psychological disturbances.
17.Uncontrolled systemic conditions like Diabetes mellitus.
18.Cirrhosis of the Liver
19.Coagulopathies.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method